Becton Dickinson & Co.: Medical Device Recall in 2024 - (Recall #: Z-1023-2024)

Updated on March 25, 2026.

See the recall detail below. You can also see other recalls from the same firm in 2024.

Data Source: FDA.

Product Description:

BD BBL Sensi Disc Ceftazidime- 30 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231632¿and 231633¿

Product Classification:

Class II

Date Initiated: January 8, 2024

Date Posted: February 14, 2024

Recall Number: Z-1023-2024

Event ID: 93789

Reason for Recall:

There is a possibility of reproducibility, accuracy, and/or QC failures in antibiotic susceptibility testing (AST) for H. influenzae. This may cause product discard, delayed results, or additional adverse diagnostic outcomes, such as a delay in diagnosis, the selection of inappropriate antibiotics, or extended duration of antibiotic exposure and the treatment process.

Status: Ongoing

Product Quantity: 2,363,168 total units

Code Information:

Catalog No. 231632¿ UDI-DI 00382902316329 Lots 2004587 2028883 2119589 2146527 2242568 2301371 3118111 3181037; Catalog No. 231633¿ UDI-DI 30382902316337 Lots 2242568 2301371 3062286 3118111 3181037 3223389 3290192 2004587 2028232 2028883 2028894 2056528 2119589 2146527

Distribution Pattern:

Domestic distribution nationwide. International distribution worldwide.

Voluntary or Mandated:

Voluntary: Firm initiated